- Home
- LOCO vs TERN Comparison
LOCO vs TERN Comparison
Compare LOCO & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCO
- TERN
- Stock Information
- Founded
- LOCO 1980
- TERN 2017
- Country
- LOCO United States
- TERN United States
- Employees
- LOCO N/A
- TERN N/A
- Industry
- LOCO Restaurants
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- LOCO Consumer Discretionary
- TERN Health Care
- Exchange
- LOCO Nasdaq
- TERN Nasdaq
- Market Cap
- LOCO 327.1M
- TERN 355.9M
- IPO Year
- LOCO 2014
- TERN 2021
- Fundamental
- Price
- LOCO $9.88
- TERN $3.45
- Analyst Decision
- LOCO Buy
- TERN Buy
- Analyst Count
- LOCO 3
- TERN 6
- Target Price
- LOCO $15.50
- TERN $18.30
- AVG Volume (30 Days)
- LOCO 309.6K
- TERN 1.0M
- Earning Date
- LOCO 03-06-2025
- TERN 05-12-2025
- Dividend Yield
- LOCO N/A
- TERN N/A
- EPS Growth
- LOCO 16.22
- TERN N/A
- EPS
- LOCO 0.86
- TERN N/A
- Revenue
- LOCO $473,008,000.00
- TERN N/A
- Revenue This Year
- LOCO $6.09
- TERN N/A
- Revenue Next Year
- LOCO $1.28
- TERN N/A
- P/E Ratio
- LOCO $11.48
- TERN N/A
- Revenue Growth
- LOCO 0.93
- TERN N/A
- 52 Week Low
- LOCO $8.17
- TERN $3.24
- 52 Week High
- LOCO $14.25
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- LOCO 25.64
- TERN 36.30
- Support Level
- LOCO $10.25
- TERN $3.24
- Resistance Level
- LOCO $11.08
- TERN $3.68
- Average True Range (ATR)
- LOCO 0.52
- TERN 0.24
- MACD
- LOCO -0.12
- TERN 0.02
- Stochastic Oscillator
- LOCO 0.95
- TERN 26.92
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.